Friday, October 18, 2013

Isaac Kinde - Forbes Top 30 Under 30 in Biotech and Life Sciences-Video

MD-PhD Candidate, Johns Hopkins School of Medicine
Kinde is developing techniques to improve the accuracy of DNA sequencing technology and demonstrating that it might be used to detect cancers arising from the colon, pancreas, and ovaries in a simple, noninvasive manner. Already, several patents have been applied for and he's been published in Science Translational Medicine, Nature and other journals.